Vortioxetine Hydrobromide
Brand name: Trintellix
Rank #142 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$113.9M
Total Cost
197,873
Total Claims
$113.9M
Total Cost
7,338
Prescribers
$576
Cost per Claim
7,984
Beneficiaries
242,690
30-Day Fills
$16K
Avg Cost/Provider
27
Avg Claims/Provider
Share of Medicare Part D Spending
0.04%
of total Medicare Part D spending
$113.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $113.9M total
🔎 Data Overview
Average cost of $14,269 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Vortioxetine Hydrobromide
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Robert Morton | Psychiatry | Ada, OK | 2,904 | $1.2M |
| 2 | Sea Chung | Internal Medicine | Flushing, NY | 543 | $330K |
| 3 | Nilda Garcia Silva | Psychiatry | San Juan, PR | 805 | $319K |
| 4 | Tatyana Tsipursky | Psychiatry | Brooklyn, NY | 512 | $267K |
| 5 | Edward Sathoff | Psychiatry | Mankato, MN | 332 | $238K |
| 6 | Simon Mcclure | Psychiatry | Bridgeport, WV | 356 | $217K |
| 7 | Asya Kupisk | Psychiatry | Los Angeles, CA | 392 | $200K |
| 8 | Venitius Nunez | Psychiatry | Marlton, NJ | 387 | $195K |
| 9 | Ileana Berman | Psychiatry | Attleboro, MA | 343 | $193K |
| 10 | Thomas Winegarden | Psychiatry | Chanhassen, MN | 267 | $189K |
| 11 | Ramon Ravelo | Psychiatry | New York, NY | 330 | $185K |
| 12 | Sarah Dixon-Bowdell | Nurse Practitioner | Sarasota, FL | 387 | $177K |
| 13 | Homayoun Sharim | Internal Medicine | Beverly Hills, CA | 219 | $172K |
| 14 | Afshine Emrani | Cardiology | Tarzana, CA | 237 | $169K |
| 15 | Michael Saribalas | Sleep Medicine | Columbus, OH | 262 | $159K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 139 | Ambrisentan (Ambrisentan) | $117.7M | 23,927 |
| 140 | Memantine Hcl (Memantine Hcl) | $117.5M | 2,268,098 |
| 141 | Estradiol (Estradiol) | $115.7M | 1,412,386 |
| 142 | Vortioxetine Hydrobromide (Trintellix) | $113.9M | 197,873 |
| 143 | Asfotase Alfa (Strensiq) | $113.8M | 1,142 |
| 144 | Erenumab-Aooe (Aimovig Autoinjector) | $111.9M | 118,455 |
| 145 | Corticotropin (Acthar) | $111.6M | 1,633 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology